SI2748147T1 - Substituirani 2-alkil-1-okso-N-fenil-3-heteroaril-1,2,3,4-tetrahidroizokinolin-4-kar- boksamidi za antimalarične terapije - Google Patents

Substituirani 2-alkil-1-okso-N-fenil-3-heteroaril-1,2,3,4-tetrahidroizokinolin-4-kar- boksamidi za antimalarične terapije

Info

Publication number
SI2748147T1
SI2748147T1 SI201231080T SI201231080T SI2748147T1 SI 2748147 T1 SI2748147 T1 SI 2748147T1 SI 201231080 T SI201231080 T SI 201231080T SI 201231080 T SI201231080 T SI 201231080T SI 2748147 T1 SI2748147 T1 SI 2748147T1
Authority
SI
Slovenia
Prior art keywords
tetrahydroisoquinoline
carboxamides
heteroaryl
oxo
phenyl
Prior art date
Application number
SI201231080T
Other languages
English (en)
Inventor
Rodney Kiplin Guy
Fangyi Zhu
Wendyam Armand Guiguemde
David Floyd
Spencer Knapp
Philip Stein
Steve Castro
Original Assignee
St. Jude Children's Research Hospital
Mmv Mediciens For Malaria Venture
Rutgers, The State University Of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St. Jude Children's Research Hospital, Mmv Mediciens For Malaria Venture, Rutgers, The State University Of New Jersey filed Critical St. Jude Children's Research Hospital
Publication of SI2748147T1 publication Critical patent/SI2748147T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI201231080T 2011-08-25 2012-08-24 Substituirani 2-alkil-1-okso-N-fenil-3-heteroaril-1,2,3,4-tetrahidroizokinolin-4-kar- boksamidi za antimalarične terapije SI2748147T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161527594P 2011-08-25 2011-08-25
PCT/IB2012/054305 WO2013027196A1 (en) 2011-08-25 2012-08-24 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies
EP12772470.6A EP2748147B1 (en) 2011-08-25 2012-08-24 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinoline-4-carboxamides for antimalarial therapies

Publications (1)

Publication Number Publication Date
SI2748147T1 true SI2748147T1 (sl) 2017-11-30

Family

ID=47018313

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201231080T SI2748147T1 (sl) 2011-08-25 2012-08-24 Substituirani 2-alkil-1-okso-N-fenil-3-heteroaril-1,2,3,4-tetrahidroizokinolin-4-kar- boksamidi za antimalarične terapije

Country Status (19)

Country Link
US (1) US9416124B2 (sl)
EP (1) EP2748147B1 (sl)
JP (1) JP6035334B2 (sl)
CN (1) CN103930404B (sl)
BR (1) BR112014004437B1 (sl)
CA (1) CA2846507C (sl)
CY (1) CY1119748T1 (sl)
DK (1) DK2748147T3 (sl)
ES (1) ES2644082T3 (sl)
HK (1) HK1199443A1 (sl)
HR (1) HRP20171567T1 (sl)
HU (1) HUE034721T2 (sl)
LT (1) LT2748147T (sl)
ME (1) ME02908B (sl)
PL (1) PL2748147T3 (sl)
PT (1) PT2748147T (sl)
RS (1) RS56544B1 (sl)
SI (1) SI2748147T1 (sl)
WO (1) WO2013027196A1 (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200134203A (ko) * 2017-08-21 2020-12-01 나비젠, 인코포레이티드 Arf6 억제제 및 관련 방법
EP3892332A1 (en) 2020-04-09 2021-10-13 University Of Kentucky Research Foundation New anti-malarial agents
JP2024515336A (ja) 2021-04-15 2024-04-08 アールディーピー ファーマ アーゲー 抗ウイルス剤及び抗腫瘍剤として使用するためのイソキノリン誘導体
EP4074314A1 (en) * 2021-04-15 2022-10-19 Valdospan GmbH Isoquinoline derivatives for use as antiviral and antitumour agents
WO2024083802A1 (en) 2022-10-17 2024-04-25 Valdospan Gmbh Isoquinoline derivatives as protein degraders, e7 degraders, antivirals, tumor therapeutics and immune suppressives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639761A (en) * 1994-02-14 1997-06-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof
US5409938A (en) * 1994-02-14 1995-04-25 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Antimalarial korupensamines and pharmaceutical compositions and medical uses thereof
US6921762B2 (en) * 2001-11-16 2005-07-26 Amgen Inc. Substituted indolizine-like compounds and methods of use
WO2004004727A1 (en) * 2002-07-03 2004-01-15 Axys Pharmaceuticals, Inc. 3,4-dihydroisoquinolin-1-one derivatives as inducers of apoptosis
DE10237722A1 (de) 2002-08-17 2004-08-19 Aventis Pharma Deutschland Gmbh Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
DE10312963A1 (de) 2003-03-24 2004-10-07 Aventis Pharma Deutschland Gmbh Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
PE20100737A1 (es) * 2005-03-25 2010-11-27 Glaxo Group Ltd Nuevos compuestos
RU2302417C1 (ru) 2006-03-14 2007-07-10 Иващенко Андрей Александрович 1-оксо-3-(1н-индол-3-ил)-1,2,3,4-тетрагидроизохинолины, способы их получения, комбинаторная библиотека и фокусированная библиотека
US20110281869A1 (en) * 2008-05-19 2011-11-17 Hamed Aissaoui Tetrahydroisoquinolines as antimalarial agents
GB0820856D0 (en) 2008-11-14 2008-12-24 Univ Leuven Kath Novel inhibitors of flavivirus replication

Also Published As

Publication number Publication date
EP2748147A1 (en) 2014-07-02
RS56544B1 (sr) 2018-02-28
US9416124B2 (en) 2016-08-16
PT2748147T (pt) 2017-11-14
CN103930404B (zh) 2016-08-24
WO2013027196A1 (en) 2013-02-28
US20140235593A1 (en) 2014-08-21
BR112014004437A8 (pt) 2018-01-23
LT2748147T (lt) 2017-10-25
JP2014524464A (ja) 2014-09-22
EP2748147B1 (en) 2017-08-02
CA2846507A1 (en) 2013-02-28
BR112014004437A2 (pt) 2017-03-28
PL2748147T3 (pl) 2018-01-31
HK1199443A1 (en) 2015-07-03
CA2846507C (en) 2020-03-10
CY1119748T1 (el) 2018-06-27
HRP20171567T1 (hr) 2017-11-17
ES2644082T3 (es) 2017-11-27
ME02908B (me) 2018-10-20
CN103930404A (zh) 2014-07-16
BR112014004437B1 (pt) 2021-12-14
HUE034721T2 (hu) 2018-02-28
JP6035334B2 (ja) 2016-11-30
WO2013027196A9 (en) 2013-04-18
DK2748147T3 (da) 2017-11-13

Similar Documents

Publication Publication Date Title
EP2875029B8 (en) 5,5-heteroaromatic anti-infective compounds
EP2688642A4 (en) neurostimulator
EP2762476A4 (en) 1,2,4-triazine-6-carboxamide derivative
PT2551190E (pt) Avião convertível
PL2551198T3 (pl) Zmiennopłat
EP2935214A4 (en) 1,4-PYRIDONES COMPOUNDS
GB201216143D0 (en) .
EP2699091A4 (en) 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS
HK1192757A1 (zh) 取代的 -芳基- -苯基- -三嗪- -胺
GB201203412D0 (en) .
HK1199443A1 (en) Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahyd roisoquinoline-4-carboxamides for antimalarial therapies 2--1--n--3--1,2,3,4- -4-
GB201112922D0 (en) Micro-organ
GB201203063D0 (en) .
GB201115344D0 (en) The FitCase
HK1191942A1 (zh) 新型六氫環戊二烯並吡咯酮,六氫吡咯並吡咯酮,八氫吡咯並吡啶酮和八氫吡啶酮化合物
GB201112721D0 (en) Antimalarial
GB201115921D0 (en) The Denness fast-loo
GB201203786D0 (en) .
GB201204535D0 (en) .
GB201204735D0 (en) The quadtrolley
GB201120548D0 (en) .
GB201120676D0 (en) The degravitator
GB201113021D0 (en) .
GB201103842D0 (en) .
GB201112500D0 (en) The degravitator